Physical violence and aggression in Parkinson's disease a systematic review.

Parkinson disease aggression deep brain stimulation violence

Journal

Journal of the Academy of Consultation-Liaison Psychiatry
ISSN: 2667-2960
Titre abrégé: J Acad Consult Liaison Psychiatry
Pays: Netherlands
ID NLM: 101775059

Informations de publication

Date de publication:
02 Feb 2024
Historique:
received: 22 09 2023
revised: 10 01 2024
accepted: 28 01 2024
medline: 5 2 2024
pubmed: 5 2 2024
entrez: 4 2 2024
Statut: aheadofprint

Résumé

Physical violence and aggression (PVA), defined as behaviors with the potential to cause bodily injury, are unfortunate risks in the management of all-cause neurodegenerative dementias. Whereas dementia in Parkinson's disease (PD) may not be evident for many years after clinical onset, neuropsychiatric disturbances occur at all stages of the disease. At issue is whether PVA in PD is associated with clinical factors that can be targets for prevention and management in the absence of a prevailing dementia syndrome. This systematic review examined the extent to which PVA in PD without dementia is a clinically significant concern and whether it is associated with factors that could warrant proactive management. A systematic search of 9 electronic databases used MeSH headings and equivalent terms for PD, aggression, and violence. Eligible manuscripts were original articles that were published in peer-reviewed journals and reported on adults with PD in the awake state with PVA as possible outcomes. Extracted data included study design, PD ascertainment methods and characteristics, PVA assessment methods, subject demographics, psychiatric and medical comorbidities, and pertinent results. Inciting and confounding factors were extracted from case reports. Quality assessment tools were applied in accordance with the study design (e.g., observational, qualitative, or case report). The search identified 10 manuscripts: two observational quantitative studies (total n with PD = 545), one qualitative study (n with PD = 20), and seven case reports (n = 7). The observational studies suggested that PVA is less common than other neuropsychiatric disturbances, but heterogeneous methods and quality concerns prevented further conclusions. In the case reports, all patients were male, and most were early onset. In six of the reports, PVA occurred in the context of bilateral subthalamic nucleus deep brain stimulation (STN-DBS). PVA, while relatively rare in PD, can be a significant management issue that is associated with select premorbid characteristics and antiparkinsonian motor treatments. As PVA may be under-reported, further understanding of its frequency, causes, risk factors, and outcomes would benefit from its systematic assessment, ideally using self-report and informant-based questionnaires.

Sections du résumé

BACKGROUND BACKGROUND
Physical violence and aggression (PVA), defined as behaviors with the potential to cause bodily injury, are unfortunate risks in the management of all-cause neurodegenerative dementias. Whereas dementia in Parkinson's disease (PD) may not be evident for many years after clinical onset, neuropsychiatric disturbances occur at all stages of the disease. At issue is whether PVA in PD is associated with clinical factors that can be targets for prevention and management in the absence of a prevailing dementia syndrome.
OBJECTIVE OBJECTIVE
This systematic review examined the extent to which PVA in PD without dementia is a clinically significant concern and whether it is associated with factors that could warrant proactive management.
METHODS METHODS
A systematic search of 9 electronic databases used MeSH headings and equivalent terms for PD, aggression, and violence. Eligible manuscripts were original articles that were published in peer-reviewed journals and reported on adults with PD in the awake state with PVA as possible outcomes. Extracted data included study design, PD ascertainment methods and characteristics, PVA assessment methods, subject demographics, psychiatric and medical comorbidities, and pertinent results. Inciting and confounding factors were extracted from case reports. Quality assessment tools were applied in accordance with the study design (e.g., observational, qualitative, or case report).
RESULTS RESULTS
The search identified 10 manuscripts: two observational quantitative studies (total n with PD = 545), one qualitative study (n with PD = 20), and seven case reports (n = 7). The observational studies suggested that PVA is less common than other neuropsychiatric disturbances, but heterogeneous methods and quality concerns prevented further conclusions. In the case reports, all patients were male, and most were early onset. In six of the reports, PVA occurred in the context of bilateral subthalamic nucleus deep brain stimulation (STN-DBS).
CONCLUSIONS CONCLUSIONS
PVA, while relatively rare in PD, can be a significant management issue that is associated with select premorbid characteristics and antiparkinsonian motor treatments. As PVA may be under-reported, further understanding of its frequency, causes, risk factors, and outcomes would benefit from its systematic assessment, ideally using self-report and informant-based questionnaires.

Identifiants

pubmed: 38311061
pii: S2667-2960(24)00015-6
doi: 10.1016/j.jaclp.2024.01.007
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Melissa B Jones (MB)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX, 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030. Electronic address: melissa.jones2@bcm.edu.

Lakeshia Gibson (L)

University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216, Present address: Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115. Electronic address: lgibson6@bwh.harvard.edu.

Malena Gimenez-Zapiola (M)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: malena.gimenezzapiola@bcm.edu.

Ana Guerra (A)

Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030., Present address: Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098. Electronic address: aganaguerra@gmail.com.

Gursimrat Bhatti (G)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: gursimrat.bhatti@bcm.edu.

Dakota Broadway (D)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: dakota.broadway@bcm.edu.

Juliann Tea (J)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: juliann.tea2@va.gov.

Aksa Prasad (A)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030., Present address: The University of Texas Rio Grande Valley, 1201 W. University Dr., Edinburg, TX, 78539. Electronic address: aksaprasad1@gmail.com.

Rachel Gates (R)

Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030., Present address: UCHealth University of Colorado Hospital, 12605 E. 16th Ave., Aurora, CO, 80045. Electronic address: gates.rachelp@gmail.com.

Elizabeth Hinton (E)

University of Mississippi Medical Center, 2500 North State Street, Jackson, MS, 39216. Electronic address: ehinton@umc.edu.

Ricardo E Jorge (RE)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: ricardo.jorge@bcm.edu.

Laura Marsh (L)

Michael E. DeBakey VA Medical Center, 2002 Holcombe Blvd., Houston, TX 77098; Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030. Electronic address: laura.marsh2@va.gov.

Classifications MeSH